Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) Compared to Placebo in Migraine Prevention
Clinical trial NCT02483585 · COMPLETED
Trial details
- NCT number
- NCT02483585
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-20
- Primary completion
- 2016-07-11
- Enrollment
- 577
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.